Results 211 to 220 of about 18,575 (296)
This paper reviews the state of the art and recent developments in thin‐film biosensors for the detection of neurotransmitters, small molecules, and biomarkers within flexible, implantable bioelectronic systems. It covers the main sensing modalities, including electrochemical, plasmonic, acoustic, and magnetic, alongside their materials, transduction ...
Massimo Mariello
wiley +1 more source
This study establishes pharmacological microglial inhibition as a therapeutic strategy, demonstrating its capacity to remodel the lesion microenvironment through significant reduction of extracellular matrix deposition. This permissive environmental transformation facilitates robust regeneration of the reticulospinal tract, and reconstructs functional ...
Run Li +11 more
wiley +1 more source
Current use of neuromuscular blocking agents and antagonists in Korea: a 2018 survey. [PDF]
Kim JS +8 more
europepmc +1 more source
Schematic of the proposed method. A K‐nearest‐neighbors clustering‐based pretraining strategy was adopted to ensure similarity between the data used for pretraining and that of a new user. Besides, the proposed method pioneeringly utilized an attention mechanism to learn the relationship between muscles and hand movements for finger‐joint‐angle ...
Zhouping Chen +3 more
wiley +1 more source
Association between reversal agents (sugammadex vs. neostigmine) for neuromuscular block and postoperative pulmonary complications: A retrospective analysis [PDF]
Aolin Ren +8 more
openalex +1 more source
6/7 patients achieved CMI by the third follow‐up, sustained to the fourth follow‐up, and 4/6 reached MSE by the fifth follow‐up. First real‐world evidence of adding telitacicept efficacy in refractory ocular MG symptoms Abstract Introduction Refractory ocular myasthenia gravis (MG) represents a significant therapeutic challenge, as conventional ...
Jing Lin +4 more
wiley +1 more source
Custom illustration created by the author in collaboration with the Mayo Clinic Digital Media Department. ABSTRACT Immune checkpoint‐inhibitors (ICIs) have revolutionized and significantly improved cancer care through remarkable efficacy, but significant adverse effects have been observed.
Artur Schneider +3 more
wiley +1 more source

